Direct generation of induced pluripotent stem cells from human nonmobilized blood

Stem Cells and Development

Volumn 20, Issue 1, 2011, Pages 159-168

  Kunisato, Atsushi ^a   Wakatsuki, Mariko ^a   Shinba, Haruna ^a   Ota, Toshio ^a   Ishida, Isao ^a   Nagao, Kenji ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; KRUPPEL LIKE FACTOR 4; MEMBRANE ANTIGEN; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR SOX2;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; BLOOD CELLS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CLONE CELLS; DNA METHYLATION; GENE REARRANGEMENT; GENOME, HUMAN; GERM CELLS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; INDUCED PLURIPOTENT STEM CELLS; LEUKOCYTES, MONONUCLEAR; MALE; PROMOTER REGIONS, GENETIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TISSUE DONORS;

EID: 78650977507     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2010.0063     Document Type: Article

References (35)

1. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
2. Okita K, T Ichisaka and S Yamanaka. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317.
3. Wernig M, A Meissner, R Foreman, T Brambrink, M Ku, K Hochedlinger, BE Bernstein and R Jaenisch. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448:318-324. (Pubitemid 47080337)
4. Meissner A, M Wernig and R Jaenisch. (2007). Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 25:1177-1181.
5. Maherali N, R Sridharan, W Xie, J Utikal, S Eminli, K Arnold, M Stadtfeld, R Yachechko, J Tchieu, R Jaenisch, K Plath and K Hochedlinger. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1:55-70.
6. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
7. Aasen T, A Raya, MJ Barrero, E Garreta, A Consiglio, F Gonzalez, R Vassena, J Bilic, V Pekarik, G Tiscornia, M Edel, S Boue and JC Belmonte. (2008). Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26:1276-1284.
8. Hanna J, K Saha, B Pando, J van Zon, CJ Lengner, MP Creyghton, A van Oudenaarden and R Jaenisch. (2009). Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462:595-601.
9. Kunisato A, M Wakatsuki, Y Kodama, H Shinba, I Ishida and K Nagao. (2009). Generation of induced pluripotent stem (iPS) cells by efficient reprogramming of adult bone marrow cells. Stem Cells Dev 19:229-238.
10. Loh YH, S Agarwal, IH Park, A Urbach, H Huo, GC Heffner, K Kim, JD Miller, K Ng and GQ Daley. (2009). Generation of induced pluripotent stem cells from human blood. Blood 113:5476-5479.
11. Ye Z, H Zhan, P Mali, S Dowey, DM Williams, YY Jang, CV Dang, JL Spivak, AR Moliterno and L Cheng. (2009). Human induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114:5473-5480.
12. Anderlini P. (2009). Effects and safety of granulocyte colonystimulating factor in healthy volunteers. Curr Opin Hematol 16:35-40.
13. Daheron L, SL Opitz, H Zaehres, MW Lensch, PW Andrews, J Itskovitz-Eldor and GQ Daley. (2004). LIF=STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 22:770-778.
14. Niwa H, T Burdon, I Chambers and A Smith. (1998). Selfrenewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 12:2048-2060.
15. Heike T and T Nakahata. (2002). Ex vivo expansion of hematopoietic stem cells by cytokines. Biochim Biophys Acta 1592:313-321.
16. Fischer M, J Goldschmitt, C Peschel, JP Brakenhoff, KJ Kallen, A Wollmer, J Grotzinger and S Rose-John (1997). I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol 15:142-145.
17. Mizuguchi H, H Mizuno, K Yasukawa, T Ishiguro, K Fukui, T Imanaka and M Takagi. (2001). Enhanced signal transduction by a directly fused protein of interleukin-6 and its receptor. J Biosci Bioeng 91:299-304.
18. Kitamura T, Y Koshino, F Shibata, T Oki, H Nakajima, T Nosaka and H Kumagai. (2003). Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 31:1007-1014.
19. Morita S, T Kojima and T Kitamura. (2000). Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7:1063-1066.
20. Masaki H, T Ishikawa, S Takahashi, M Okumura, N Sakai, M Haga, K Kominami, H Migita, F McDonald, F Shimada and K Sakurada. (2007). Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction culture. Stem Cell Res 1:105-115.
21. Tesar PJ, JG Chenoweth, FA Brook, TJ Davies, EP Evans, DL Mack, RL Gardner and RD McKay. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448:196-199.
22. Hong H, K Takahashi, T Ichisaka, T Aoi, O Kanagawa, M Nakagawa, K Okita and S Yamanaka. (2009). Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460:1132-1135.
23. Chan EM, S Ratanasirintrawoot, IH Park, PD Manos, YH Loh, H Huo, JD Miller, O Hartung, J Rho, TA Ince, GQ Daley and TM Schlaeger. (2009). Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 27:1033-1037.
24. van Dongen JJ, AW Langerak, M Bruggemann, PA Evans, M Hummel, FL Lavender, E Delabesse, F Davi, E Schuuring, R Garcia-Sanz, JH van Krieken, J Droese, D Gonzalez, C Bastard, HE White, M Spaargaren, M Gonzalez, A Parreira, JL Smith, GJ Morgan, M Kneba and EA Macintyre. (2003). Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257-2317.
25. Kawamura T, J Suzuki, YV Wang, S Menendez, LB Morera, A Raya, GM Wahl and JC Belmonte. (2009). Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460:1140-1144.
26. Utikal J, JM Polo, M Stadtfeld, N Maherali, W Kulalert, RM Walsh, A Khalil, JG Rheinwald and K Hochedlinger. (2009). Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460:1145-1148.
27. Marion RM, K Strati, H Li, M Murga, R Blanco, S Ortega, O Fernandez-Capetillo, M Serrano and MA Blasco. (2009). A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460:1149-1153.
28. Li H, M Collado, A Villasante, K Strati, S Ortega, M Canamero, MA Blasco and M Serrano. (2009). The Ink4=Arf locus is a barrier for iPS cell reprogramming. Nature 460:1136-1139.
29. Zhao Y, X Yin, H Qin, F Zhu, H Liu, W Yang, Q Zhang, C Xiang, P Hou, Z Song, Y Liu, J Yong, P Zhang, J Cai, M Liu, H Li, Y Li, X Qu, K Cui, WZhang, T Xiang, Y Wu, Y Zhao, C Liu, C Yu, K Yuan, J Lou, M Ding and H Deng. (2008). Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3:475-479.
30. Takenaka C, N Nishishita, N Takada, LM Jakt and S Kawamata. (2009). Effective generation of iPS cells from CD34() cord blood cells by inhibition of p53. Exp Hematol 38:154-162.
31. Hanna J, S Markoulaki, M Mitalipova, AW Cheng, JP Cassady, J Staerk, BW Carey, CJ Lengner, R Foreman, J Love, Q Gao, J Kim and R Jaenisch. (2009). Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell 4:513-524.
32. Eminli S, A Foudi, M Stadtfeld, N Maherali, T Ahfeldt, G Mostoslavsky, H Hock and K Hochedlinger. (2009). Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 41:968-976.
33. Sun N, NJ Panetta, DM Gupta, KD Wilson, A Lee, F Jia, S Hu, AM Cherry, RC Robbins, MT Longaker and JC Wu. (2009). Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 106:15720-15725.
34. Haase A, R Olmer, K Schwanke, S Wunderlich, S Merkert, C Hess, R Zweigerdt, I Gruh, J Meyer, S Wagner, LS Maier, DW Han, S Glage, K Miller, P Fischer, HR Scholer and U Martin. (2009). Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5:434-441.
35. Giorgetti A, N Montserrat, T Aasen, F Gonzalez, I Rodriguez-Piza, R Vassena, A Raya, S Boue, MJ Barrero, BA Corbella, M Torrabadella, A Veiga and JC Izpisua Belmonte. (2009). Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5:353-357.